Momentum Fund News
January 14, 2021
Veralox Therapeutics Announces IND Submission for VLX-1005 to Treat Heparin-Inducted Thrombocytopenia
FREDERICK, Md.--(BUSINESS WIRE)--Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant…
- Portfolio Company News
January 7, 2021
Working Nation: Learning language skills to access economic mobility
Voxy EnGen launches English language learning that focuses on the language of jobs “Research estimates by 2030, 97% of net workforce growth is going to be immigrants and their children. All the baby…
- Portfolio Company News
January 7, 2021
Language Upskilling Platform Raises $6.75M to Boost Economic Mobility for U.S. Immigrants and Refugees
Voxy EnGen secures $6.75 million Series A financing round to deliver personalized English training for in-demand careers in collaboration with employers, educational institutions, and community-based…
- Portfolio Company News
